Metabolic Explorer (METEX.PA)

FR0004177046 - Common Stock

0.1214  +0 (+1.17%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
50K
-85.71%		169.69M
339,280.00%		226.602M
33.54%		135.96M
-40.00%		198.79M
46.21%		260.59M
31.09%
EBITDA
YoY % growth
-9.018M
-38.78%		76.277M
945.83%		-35.463M
-146.49%		-26.78M
24.48%		-5.15M
80.77%		12.36M
340.00%
EBIT
YoY % growth
-9.652M
-15.22%		73.037M
856.70%		-43.755M
-159.91%		-31.93M
27.03%		-10.3M
67.74%		7.21M
170.00%
Operating Margin
-19,304.00%43.04%-19.31%-23.48%-5.18%2.77%
EPS
YoY % growth
N/A
33.33%		N/A
-140.00%		N/A
-77.61%		-0.84
1.90%		-0.40
52.44%		-0.09
76.92%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 69.1M
-46.56%		%
Q4 2022
Q2Q % growth		 97.3M
-26.90%		%
Q2 2022
Q2Q % growth		 129.3M
253.28%		%
Q4 2020
Q2Q % growth
-100.00%		%
Q4 2019
Q2Q % growth		 300K
-72.73%		%
Q2 2019
Q2Q % growth
-100.00%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 12.21%
RevenueN/A N/A 0% -1.23%